Alerts will be sent to your verified email
Verify EmailSANOFI
Sanofi India
|
Alkem Laboratories
|
Torrent Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
-1.2 % | 7.9 % | 11.1 % |
Unclassified
|
|||
R&D as a % of Total Sales
|
0.0 | 3.3 % | 5.0 % |
Financials
|
|||
5 yr Average ROE
|
43.25 % | 16.74 % | 17.02 % |
5yr average Equity Multiplier
|
3.33 | 1.42 | 2.5 |
5yr Average Asset Turnover Ratio
|
0.57 | 0.9 | 0.61 |
5yr Avg Net Profit Margin
|
22.99 % | 13.14 % | 11.26 % |
Price to Book
|
18.45 | 5.9 | 13.56 |
P/E
|
31.08 | 36.92 | 60.86 |
5yr Avg Cash Conversion Cycle
|
11.11 Days | 0.57 Days | -151.22 Days |
Inventory Days
|
48.47 Days | 55.43 Days | 54.43 Days |
Days Receivable
|
13.83 Days | 40.86 Days | 39.91 Days |
Days Payable
|
55.71 Days | 116.85 Days | 337.02 Days |
5yr Average Interest Coverage Ratio
|
1007.93 | 24.09 | 4.68 |
5yr Avg ROCE
|
29.56 % | 22.27 % | 21.27 % |
5yr Avg Operating Profit Margin
|
28.62 % | 19.27 % | 29.61 % |
5 yr average Debt to Equity
|
0.0 | 0.22 | 0.97 |
5yr CAGR Net Profit
|
41.96 % | 5.29 % | 23.34 % |
5yr Average Return on Assets
|
13.01 % | 11.73 % | 6.93 % |
Shareholdings
|
|||
Promoter Holding
|
60.4 % | 56.74 % | 71.25 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -3.42 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
1.86 % | 5.03 % | -2.01 % |
Sanofi India
|
Alkem Laboratories
|
Torrent Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|